Xarelto (rivaroxaban)

pCPA File Number: 20822
Negotiation Status:
Concluded with an LOI
Indication(s):
Thromboembolic events (venous), pulmonary embolism
Sponsor/Manufacturer:
Bayer Inc.
CDA-AMC Project Number:
SR0327-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: